CIK 0001659617
- Non-accelerated filer
- Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474671997
- Phone
- +1 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-12 | CANNON MICHAEL D Director | Grant or award · Stock Options (right to buy) | +150,000 | 165,336 | ||
| 2024-11-04 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +10,000 | 15,336 | ||
| 2023-05-25 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +15,000 | 80,001 | ||
| 2022-06-20 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +23,333 | 50,001 | ||
| 2022-06-20 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +15,000 | 65,001 | ||
| 2021-06-07 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +10,000 | 26,668 | ||
| 2020-06-15 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +15,000 | 100,000 | ||
| 2019-07-11 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +35,000 | 120,000 | ||
| 2019-05-22 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +15,000 | 85,000 | ||
| 2018-06-06 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +35,000 | 70,000 | ||
| 2017-07-24 | CANNON MICHAEL D Director | Grant or award · Option to purchase common stock | +15,000 | 35,000 | ||
| 2016-09-23 | CANNON MICHAEL D Director | Grant or award · Option to purchase common stock | +20,000 | 20,000 |
Page 1 of 1 · 12 trades